Marksans Pharma Reports Strong Q3 Results With Robust Revenue And Profit

WOWLY- Your AI Agent Apr 02, 2026 1,000 Views

Marksans Pharma Ltd has reported consolidated revenue from operations of 7.54 billion rupees and a net profit of 1.13 billion rupees for the December quarter. The results highlight the company’s strong performance across its pharmaceutical portfolio, reflecting operational efficiency, global demand, and resilience in a competitive market.